Epithelial mesenchymal transition traits in honey‐driven keratinocyte wound healing: Comparison among different honeys

Wound Repair and Regeneration - Tập 20 Số 5 - Trang 778-785 - 2012
Elia Ranzato1,2,3,4, Simona Martinotti1, Bruno Burlando1
1Dipartimento di Scienze e Innovazione Tecnologica, DiSIT, University of Piemonte Orientale “Amedeo Avogadro”, Alessandria, Italy
2*Email: [email protected]
3Reprint requests:
4Tel: +39 0131 360260

Tóm tắt

Abstract

Honey has been used since ancient times for wound repair, but the subjacent mechanisms are almost unknown. We have tried to elucidate the modulatory role of honey in an in vitro model of HaCaT keratinocyte re‐epithelialization by using acacia, buckwheat, and manuka honeys. Scratch wound and migration assays showed similar increases of re‐epithelialization rates and chemoattractant effects in the presence of different types of honey (0.1%, v/v). However, the use of kinase and calcium inhibitors suggested the occurrence of different mechanisms. All honeys activated cyclin‐dependent kinase 2, focal adhesion kinase, and rasGAP SH3 binding protein 1. However, vasodilator‐stimulated phosphoprotein, integrin‐β3, cdc25C, and p42/44 mitogen activated protein kinase showed variable activation pattern. Re‐epithelialization recapitulates traits of epithelial‐mesenchymal transition (EMT) and the induction of this process was evaluated by a polymerase chain reaction array, revealing marked differences among honeys. Manuka induced few significant changes in the expression of EMT‐regulatory genes, while the other two honeys acted on a wider number of genes and partially showed a common profile of up‐ and down‐regulation. In conclusion, our findings have shown that honey‐driven wound repair goes through the activation of keratinocyte re‐epithelialization, but the ability of inducing EMT varies sensibly among honeys, according to their botanical origin.

Từ khóa


Tài liệu tham khảo

10.1111/j.1365-2672.1992.tb04993.x

10.1016/S0378-8741(02)00377-X

10.2165/11538930-000000000-00000

10.1097/01.ASW.0000305460.87058.42

10.1177/1534734605286014

10.1007/BF02033065

10.2165/00128071-200102010-00003

10.1100/tsw.2011.78

10.1155/2011/239864

10.1097/01.prs.0000225430.42531.c2

10.1111/j.1365-2133.2008.08699.x

10.1016/j.intimp.2005.08.014

10.1002/ptr.2990

10.12968/jowc.2008.17.4.28839

10.1046/j.1365-2672.2002.01761.x

10.1007/s10096-010-0992-1

10.1186/1472-6882-1-2

10.1111/j.1742-481X.2007.00424.x

10.1111/j.1365-2702.2008.02558.x

10.1083/jcb.106.3.761

10.1111/j.1600-0625.2010.01173.x

10.1111/j.1582-4934.2008.00467.x

10.1016/j.cpm.2009.07.002

10.1016/S0074-7696(01)07004-8

10.1038/onc.2008.358

10.2353/ajpath.2008.071124

10.1021/pr0340983

10.1111/j.1537-2995.2004.03366.x

10.1016/j.jep.2010.12.042

10.1016/j.matbio.2009.01.001

10.1016/j.devcel.2011.08.007

10.1111/j.1600-0625.2009.00994.x

10.1016/j.jdermsci.2010.11.015

Hoot KE, 2008, Keratinocyte‐specific Smad2 ablation results in increased epithelial‐mesenchymal transition during skin cancer formation and progression, J Clin Invest, 118, 2722

10.2741/2985

10.1038/nature03688